Nk cell receptor/H2-Dk-dependent host resistance to viral infection is quantitatively modulated by H2q inhibitory signals

PLoS Genetics

Volumn 7, Issue 4, 2011, Pages

  Fodil Cornu, Nassima ^a   Loredo Osti, J Concepción ^b   Vidal, Silvia M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HOST RESISTANCE; IN VIVO STUDY; INFECTION RESISTANCE; INFECTION SENSITIVITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN PROTEIN INTERACTION; VIRUS IMMUNITY; VIRUS LOAD; ANIMAL; CELL CULTURE; CONGENIC STRAIN; GENE; GENE FREQUENCY; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; MOUSE STRAIN; MUROMEGALOVIRUS; PATHOGENICITY; PHENOTYPE; TRANSGENE; TRANSGENIC MOUSE; VIROLOGY;

CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS; MUS;

ANIMALS; CELLS, CULTURED; GENE FREQUENCY; GENES, MHC CLASS I; HERPESVIRIDAE INFECTIONS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MICE; MICE, CONGENIC; MICE, INBRED STRAINS; MICE, TRANSGENIC; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; PHENOTYPE; RECEPTORS, NATURAL KILLER CELL; TRANSGENES; VIRAL LOAD;

EID: 79955599179     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1001368     Document Type: Article

References (57)

1. Raulet DH, Guerra N, (2009) Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol 9: 568-580.
2. Lodoen MB, Lanier LL, (2006) Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18: 391-398.
3. Guan H, Moretto M, Bzik DJ, Gigley J, Khan IA, (2007) NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway. J Immunol 179: 590-596.
4. Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, et al. (2005) Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 175: 4611-4617.
5. Gonzalez VD, Landay AL, Sandberg JK, (2010) Innate immunity and chronic immune activation in HCV/HIV-1 co-infection. Clin Immunol 135: 12-25.
6. Ward J, Barker E, (2008) Role of natural killer cells in HIV pathogenesis. Curr HIV/AIDS Rep 5: 44-50.
7. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP, (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189-220.
8. Ortaldo JR, Young HA, (2005) Mouse Ly49 NK receptors: balancing activation and inhibition. Mol Immunol 42: 445-450.
9. Karre K, (1991) MHC gene control of the natural killer system at the level of the target and the host. Semin Cancer Biol 2: 295-309.
10. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, et al. (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
11. Yokoyama WM, Kim S, (2006) How do natural killer cells find self to achieve tolerance? Immunity 24: 249-257.
12. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
13. Jonsson AH, Yang L, Kim S, Taffner SM, Yokoyama WM, (2010) Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J Immunol 184: 3424-3432.
14. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, et al. (1997) Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 155: 41-52.
15. Raulet DH, Vance RE, McMahon CW, (2001) Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 19: 291-330.
16. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
17. Yokoyama WM, Kim S, (2006) Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 214: 143-154.
18. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, et al. (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2: 951-956.
19. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517-523.
20. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH, (2000) Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1: 119-126.
21. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, et al. (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99: 8826-8831.
22. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL, (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
23. Bubic I, Wagner M, Krmpotic A, Saulig T, Kim S, et al. (2004) Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78: 7536-7544.
24. Fodil-Cornu N, Lee SH, Belanger S, Makrigiannis AP, Biron CA, et al. (2008) Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J Immunol 181: 6394-6405.
25. Desrosiers MP, Kielczewska A, Loredo-Osti JC, Adam SG, Makrigiannis AP, et al. (2005) Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 37: 593-599.
26. Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB, et al. (2009) Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med 206: 515-523.
27. Chalmer JE, Mackenzie JS, Stanley NF, (1977) Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol 37: 107-114.
28. Dighe A, Rodriguez M, Sabastian P, Xie X, McVoy M, et al. (2005) Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J Immunol 175: 6820-6828.
29. Xie X, Dighe A, Clark P, Sabastian P, Buss S, et al. (2007) Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins. J Virol 81: 229-236.
30. Klein J, (1973) List of congenic lines of mice. I. Lines with differences at alloantigen loci. Transplantation 15: 137-153.
31. Makrigiannis AP, Pau AT, Saleh A, Winkler-Pickett R, Ortaldo JR, et al. (2001) Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol 166: 5034-5043.
32. Johansson S, Salmon-Divon M, Johansson MH, Pickman Y, Brodin P, et al. (2009) Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice. PLoS ONE 4: e6046 doi:10.1371/journal.pone.0006046.
33. Oberg L, Johansson S, Michaelsson J, Tomasello E, Vivier E, et al. (2004) Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo- role of KARAP/DAP12-dependent and-independent pathways. Eur J Immunol 34: 1646-1653.
34. Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, et al. (1999) Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67-77.
35. Xie X, Stadnisky MD, Coats ER, Ahmed Rahim MM, Lundgren A, et al. MHC class I D(k) expression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirus. Proc Natl Acad Sci U S A 107: 8754-8759.
36. Webb JR, Lee SH, Vidal SM, (2002) Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match. Genes Immun 3: 250-262.
37. Jonsson AH, Yang L, Kim S, Taffner SM, Yokoyama WM, Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J Immunol 184: 3424-3432.
38. Kavanagh DG, Gold MC, Wagner M, Koszinowski UH, Hill AB, (2001) The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J Exp Med 194: 967-978.
39. Sun JC, Lanier LL, (2008) Cutting edge: viral infection breaks NK cell tolerance to "missing self". J Immunol 181: 7453-7457.
40. Chalifour A, Roger J, Lemieux S, Duplay P, (2003) Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation. Immunology 109: 58-67.
41. Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, et al. (2005) Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 79: 2920-2930.
42. LoPiccolo DM, Gold MC, Kavanagh DG, Wagner M, Koszinowski UH, et al. (2003) Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus. J Virol 77: 301-308.
43. Pinto AK, Munks MW, Koszinowski UH, Hill AB, (2006) Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J Immunol 177: 3225-3234.
44. Gazit R, Garty BZ, Monselise Y, Hoffer V, Finkelstein Y, et al. (2004) Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103: 1965-1966.
45. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
46. Carrington M, Martin MP, van Bergen J, (2008) KIR-HLA intercourse in HIV disease. Trends Microbiol 16: 620-627.
47. Price P, Witt C, de Santis D, French MA, (2007) Killer immunoglobulin-like receptor genotype may distinguish immunodeficient HIV-infected patients resistant to immune restoration diseases associated with herpes virus infections. J Acquir Immune Defic Syndr 45: 359-361.
48. Wauquier N, Padilla C, Becquart P, Leroy E, Vieillard V, (2010) Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. Immunogenetics 62: 767-771.
49. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, et al. (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173: 4273-4276.
50. Baessler T, Charton JE, Schmiedel BJ, Grunebach F, Krusch M, et al. (2010) CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells. Blood 115: 3058-3069.
51. Fodil-Cornu N, Pyzik M, Vidal SM, (2010) Use of inbred mouse strains to map recognition receptors oted cells in the NK cell gene locus. Methods Mol Biol 612: 393-409.
52. Brune W, Hengel H, Koszinowski UH, (2001) A mouse model for cytomegalovirus infection. Curr Protoc Immunol Chapter 19: Unit 19 17.
53. Wagner M, Gutermann A, Podlech J, Reddehase MJ, Koszinowski UH, (2002) Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med 196: 805-816.
54. Depatie C, Chalifour A, Pare C, Lee SH, Vidal SM, et al. (1999) Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets. Int Immunol 11: 1541-1551.
55. Kielczewska A, Kim HS, Lanier LL, Dimasi N, Vidal SM, (2007) Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein. J Immunol 178: 369-377.
56. Babic M, Pyzik M, Zafirova B, Mitrovic M, Butorac V, et al. (2010) Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. J Exp Med 207: 2663-2673.
57. Vance RE, Jamieson AM, Cado D, Raulet DH, (2002) Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc Natl Acad Sci U S A 99: 868-873.